|
1
|
Carvalho AL, Nishimoto IN, Califano JA and
Kowalski LP: Trends in incidence and prognosis for head and neck
cancer in the United States: a site-specific analysis of the SEER
database. International journal of cancer Int J Cancer.
114:806–816. 2005. View Article : Google Scholar
|
|
2
|
Bjørndal K, Krogdahl A, Therkildsen MH,
Overgaard J, Johansen J, Kristensen CA, Homøe P, Sørensen CH,
Andersen E, Bundgaard T, et al: Salivary gland carcinoma in Denmark
1990–2005: A national study of incidence, site and histology.
Results of the Danish Head and Neck Cancer Group (DAHANCA). Oral
Oncol. 47:677–682. 2011. View Article : Google Scholar
|
|
3
|
Barnes LEJ, Reichart P and Sidransky D:
World Health Organization Classification of Tumours. Pathology and
Genetics, Head and Neck Tumours. IARC Press; Lyon: 2005
|
|
4
|
Bell RB, Dierks EJ, Homer L and Potter BE:
Management and outcome of patients with malignant salivary gland
tumors. J Oral Maxillofac Surg. 63:917–928. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Buchner A, Merrell PW and Carpenter WM:
Relative frequency of intra-oral minor salivary gland tumors: A
study of 380 cases from northern California and comparison to
reports from other parts of the world. J Oral Pathol Med.
36:207–214. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Terhaard C1, Lubsen H, Van der Tweel I,
Hilgers FJ, Eijkenboom WM, Marres HA, Tjho-Heslinga RE, de Jong JM
and Roodenburg JL; Dutch Head and Neck Oncology Cooperative Group.
Salivary gland carcinoma: independent prognostic factors for
locoregional control, distant metastases, and overall survival:
results of the Dutch head and neck oncology cooperative group. Head
Neck. 26:681–692; discussion 692–683. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Whatley WS, Thompson JW and Rao B:
Salivary gland tumors in survivors of childhood cancer. Otolaryngol
Head Neck Surg. 134:385–388. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng R, Wang LE, Bondy ML, Wei Q and
Sturgis EM: Gamma radiation sensitivity and risk of malignant and
benign salivary gland tumors: A pilot case-control analysis.
Cancer. 100:561–567. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Licitra L, Grandi C, Prott FJ, Schornagel
JH, Bruzzi P and Molinari R: Major and minor salivary glands
tumours. Crit Rev Oncol Hematol. 45:215–225. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Klussmann JP, Müller A, Wagner M,
Guntinas-Lichius O, Jungehuelsing M, Sloots T, Ablashi DV and
Krueger GR: Human herpesvirus type 8 in salivary gland tumors. J
Clin Virol. 16:239–246. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Herrero R, Castellsagué X, Pawlita M,
Lissowska J, Kee F, Balaram P, Rajkumar T, Sridhar H, Rose B,
Pintos J, et al; IARC Multicenter Oral Cancer Study Group. Human
papillomavirus and oral cancer: The International Agency for
Research on Cancer multicenter study. J Natl Cancer Inst.
95:1772–1783. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Leemans CR, Braakhuis BJ and Brakenhoff
RH: The molecular biology of head and neck cancer. Nat Rev Cancer.
11:9–22. 2011. View
Article : Google Scholar
|
|
13
|
Khan MJ, Castle PE, Lorincz AT, Wacholder
S, Sherman M, Scott DR, Rush BB, Glass AG and Schiffman M: The
elevated 10-year risk of cervical precancer and cancer in women
with human papillomavirus (HPV) type 16 or 18 and the possible
utility of type-specific HPV testing in clinical practice. J Natl
Cancer Inst. 97:1072–1079. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vageli D, Sourvinos G, Ioannou M,
Koukoulis GK and Spandidos DA: High-risk human papillomavirus (HPV)
in parotid lesions. Int J Biol Markers. 22:239–244. 2007.PubMed/NCBI
|
|
15
|
Lin FC, Chen PL, Tsao TY, Li CR, Jeng KC
and Tsai SC: Prevalence of human papillomavirus and Epstein-Barr
virus in salivary gland diseases. J Int Med Res. 42:1093–1101.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Senft E, Lemound J, Stucki-Koch A,
Gellrich NC, Kreipe H and Hussein K: Expression of cyclin-dependent
kinase inhibitor 2A 16, tumour protein 53 and epidermal growth
factor receptor in salivary gland carcinomas is not associated with
oncogenic virus infection. Int J Oral Sci. 7:18–22. 2015.
View Article : Google Scholar
|
|
17
|
Bishop JA, Yonescu R, Batista D,
Yemelyanova A, Ha PK and Westra WH: Mucoepidermoid carcinoma does
not harbor transcriptionally active high risk human papillomavirus
even in the absence of the MAML2 translocation. Head Neck Pathol.
8:298–302. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Isayeva T, Said-Al-Naief N, Ren Z, Li R,
Gnepp D and Brandwein-Gensler M: Salivary mucoepidermoid carcinoma:
Demonstration of transcriptionally active human papillomavirus
16/18. Head Neck Pathol. 7:135–148. 2013. View Article : Google Scholar :
|
|
19
|
Isayeva T, Li Y, Maswahu D and
Brandwein-Gensler M: Human papillomavirus in non-oropharyngeal head
and neck cancers: A systematic literature review. Head Neck Pathol.
6(Suppl 1): S104–S120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Klussmann JP, Gültekin E, Weissenborn SJ,
Wieland U, Dries V, Dienes HP, Eckel HE, Pfister HJ and Fuchs PG:
Expression of p16 protein identifies a distinct entity of tonsillar
carcinomas associated with human papillomavirus. Am J Pathol.
162:747–753. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Reimers N, Kasper HU, Weissenborn SJ,
Stützer H, Preuss SF, Hoffmann TK, Speel EJ, Dienes HP, Pfister HJ,
Guntinas-Lichius O and Klussmann JP: Combined analysis of HPV-DNA,
p16 and EGFR expression to predict prognosis in oropharyngeal
cancer. International journal of cancer Int J Cancer.
120:1731–1738. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fakhry C and Gillison ML: Clinical
implications of human papillomavirus in head and neck cancers. J
Clin Oncol. 24:2606–2611. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Coordes A, Lenz K, Qian X, Lenarz M,
Kaufmann AM and Albers AE: Meta-analysis of survival in patients
with HNSCC discriminates risk depending on combined HPV and p16
status. Eur Arch Otorhinolaryngol. Jul 31–2015.(Epub ahead of
print). View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sepiashvili L, Bruce JP, Huang SH,
O'Sullivan B, Liu FF and Kislinger T: Novel insights into head and
neck cancer using next-generation ‘omic’ technologies. Cancer Res.
75:480–486. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wichmann G1, Rosolowski M, Krohn K, Kreuz
M, Boehm A, Reiche A, Scharrer U, Halama D, Bertolini J, Bauer U,
et al: The role of HPV RNA transcription, immune response-related
gene expression and disruptive TP53 mutations in diagnostic and
prognostic profiling of head and neck cancer. Int J Cancer.
137:2846–2857. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Klussmann JP, Mooren JJ, Lehnen M,
Claessen SM, Stenner M, Huebbers CU, Weissenborn SJ, Wedemeyer I,
Preuss SF, Straetmans JM, et al: Genetic signatures of HPV-related
and unrelated oropharyngeal carcinoma and their prognostic
implications. Clin Cancer Res. 15:1779–1786. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Luukkaa H, Klemi P, Leivo I, Vahlberg T
and Grénman R: Prognostic significance of Ki-67 and p53 as tumor
markers in salivary gland malignancies in Finland: An evaluation of
212 cases. Acta Oncol. 45:669–675. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schmitt M, Bravo IG, Snijders PJ, Gissmann
L, Pawlita M and Waterboer T: Bead-based multiplex genotyping of
human papillomaviruses. J Clin Microbiol. 44:504–512. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schmitt M, Dondog B, Waterboer T and
Pawlita M: Homogeneous amplification of genital human alpha
papillomaviruses by PCR using novel broad-spectrum GP5+
and GP6+ primers. J Clin Microbiol. 46:1050–1059. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Muñoz N, Bosch FX, de Sanjosé S, Herrero
R, Castellsagué X, Shah KV, Snijders PJ and Meijer CJ;
International Agency for Research on Cancer Multicenter Cervical
Cancer Study Group. Epidemiologic classification of human
papillomavirus types associated with cervical cancer. N Engl J Med.
348:518–527. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Van Dongen JJ, Langerak AW, Brüggemann M,
Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E,
García-Sanz R, et al: Design and standardization of PCR primers and
protocols for detection of clonal immunoglobulin and T-cell
receptor gene recombinations in suspect lymphoproliferations:
Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia.
17:2257–2317. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Klaes R, Friedrich T, Spitkovsky D, Ridder
R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D and von Knebel
Doeberitz M: Overexpression of p16(INK4A) as a specific marker for
dysplastic and neoplastic epithelial cells of the cervix uteri. Int
J Cancer. 92:276–284. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hafed L, Farag H, Shaker O and El-Rouby D:
Is human papilloma virus associated with salivary gland neoplasms?
An in situ-hybridization study. Arch Oral Biol. 57:1194–1199. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Thompson LD, Penner C, Ho NJ, Foss RD,
Miettinen M, Wieneke JA, Moskaluk CA and Stelow EB: Sinonasal tract
and nasopharyngeal adenoid cystic carcinoma: A clinicopathologic
and immunophenotypic study of 86 cases. Head Neck Pathol. 8:88–109.
2014. View Article : Google Scholar :
|
|
35
|
Qian X, Wagner S, Ma C, Coordes A, Gekeler
J, Klussmann JP, Hummel M, Kaufmann AM and Albers AE: Prognostic
significance of ALDH1A1-positive cancer stem cells in patients with
locally advanced, metastasized head and neck squamous cell
carcinoma. J Cancer Res Clin Oncol. 140:1151–1158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Qian X, Wagner S, Ma C, Klussmann JP,
Hummel M, Kaufmann AM and Albers AE: ALDH1-positive cancer
stem-like cells are enriched in nodal metastases of oropharyngeal
squamous cell carcinoma independent of HPV status. Oncol Rep.
29:1777–1784. 2013.PubMed/NCBI
|
|
37
|
Robinson M, Sloan P and Shaw R: Refining
the diagnosis of oropharyngeal squamous cell carcinoma using human
papillomavirus testing. Oral Oncol. 46:492–496. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hoffmann TK, Arsov C, Schirlau K, Bas M,
Friebe-Hoffmann U, Klussmann JP, Scheckenbach K, Balz V, Bier H and
Whiteside TL: T cells specific for HPV16 E7 epitopes in patients
with squamous cell carcinoma of the oropharynx. Int J Cancer.
118:1984–1991. 2006. View Article : Google Scholar
|
|
39
|
Ressler S, Bartkova J, Niederegger H,
Bartek J, Scharffetter-Kochanek K, Jansen-Dürr P and Wlaschek M:
p16INK4A is a robust in vivo biomarker of cellular aging in human
skin. Aging Cell. 5:379–389. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
McLaughlin-Drubin ME, Park D and Munger K:
Tumor suppressor p16INK4A is necessary for survival of cervical
carcinoma cell lines. Proc Natl Acad Sci USA. 110:16175–16180.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pauck A, Lener B, Hoell M, Kaiser A,
Kaufmann AM, Zwerschke W and Jansen-Dürr P: Depletion of the cdk
inhibitor p16INK4a differentially affects proliferation of
established cervical carcinoma cells. J Virol. 88:5256–5262. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Vékony H, Röser K, Löning T, Raaphorst FM,
Leemans CR, Van der Waal I and Bloemena E: Deregulated expression
of p16INK4a and p53 pathway members in benign and malignant
myoepithelial tumours of the salivary glands. Histopathology.
53:658–666. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li J, El-Naggar A and Mao L: Promoter
methylation of p16INK4a, RASSF1A, and DAPK is frequent in salivary
adenoid cystic carcinoma. Cancer. 104:771–776. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ciccolallo L, Licitra L, Cantú G, Gatta G
and Group EW; EUROCARE Working Group. Survival from salivary glands
adenoid cystic carcinoma in European populations. Oral Oncol.
45:669–674. 2009. View Article : Google Scholar
|
